
5,6,7-TRIMETHOXYFLAVONE
CAS No. 973-67-1
5,6,7-TRIMETHOXYFLAVONE( —— )
Catalog No. M19294 CAS No. 973-67-1
5,6,7-Trimethoxyflavone is a novel?p38-α MAPK?inhibitor with an anti-inflammatory effect. 5,6,7-Trimethoxyflavone is isolated from several?plants?including?Zeyhera tuberculosa,?Callicarpa japonica, and?Kickxia lanigera.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 69 | In Stock |
![]() ![]() |
10MG | 110 | In Stock |
![]() ![]() |
25MG | 222 | In Stock |
![]() ![]() |
50MG | 357 | In Stock |
![]() ![]() |
100MG | 573 | In Stock |
![]() ![]() |
500MG | 1197 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product Name5,6,7-TRIMETHOXYFLAVONE
-
NoteResearch use only, not for human use.
-
Brief Description5,6,7-Trimethoxyflavone is a novel?p38-α MAPK?inhibitor with an anti-inflammatory effect. 5,6,7-Trimethoxyflavone is isolated from several?plants?including?Zeyhera tuberculosa,?Callicarpa japonica, and?Kickxia lanigera.
-
Description5,6,7-Trimethoxyflavone is a novel?p38-α MAPK?inhibitor with an anti-inflammatory effect. 5,6,7-Trimethoxyflavone is isolated from several?plants?including?Zeyhera tuberculosa,?Callicarpa japonica, and?Kickxia lanigera.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number973-67-1
-
Formula Weight312.32
-
Molecular FormulaC18H16O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (106.72 mM)
-
SMILESCOc1cc2oc(cc(=O)c2c(OC)c1OC)-c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
Vidofludimus
Vidofludimus (4SC-101, SC12267) is a novel small molecule inhibitor of dihydroorotate dehydrogenase (DHODH).
-
Tamoxifen
Tamoxifen is an antagonist of the estrogen receptor in breast tissue.
-
CYD-1-79
CYD-1-79 is a potent, selective 5-HT2C receptor positive allosteric modulator (PAM).